NFKB1 and atherosclerosis: For instance, Danshinone (Tanshinone II-A) can combat atherosclerosis by inhibiting the NF-κB signaling pathway and reducing phagocytosis of oxidized LDL by macrophages, thereby inhibiting the formation of foam cells (55).